Purchases and Sales Made in Q1 2024 in Adagio Therapeutics, Inc. (ADGI)
This table provides information about the institutional ownership of Adagio Therapeutics, Inc. (ADGI) during Q1 2024. The information is specifically focused on institutions that hold shares of Adagio Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 14, 2024
Q1 2024
|
Northern Trust Corp
Chicago, IL |
BUY
|
- |
5.65K+ 5.38% |
N/A
|
111K
$366K
|
|
|
May 14, 2024
Q1 2024
|
Macquarie Group LTD
Australia, C3 |
BUY
|
- |
4.78KNew |
N/A
|
4.78K
$15.8K
|
|
|
May 09, 2024
Q1 2024
|
Belvedere Trading LLC
|
BUY
|
- |
4.29KNew |
N/A
|
4.29K
$14.2K
|
|
|
Apr 23, 2024
Q1 2024
|
Loring Wolcott & Coolidge Fiduciary Advisors LLP
|
BUY
|
- |
2KNew |
N/A
|
2K
$6.62K
|
|
|
May 03, 2024
Q1 2024
|
Trust CO Of Vermont
|
BUY
|
- |
1.25KNew |
N/A
|
1.25K
$4.14K
|
|
|
May 15, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
910+ 134.81% |
N/A
|
1.59K
$5.25K
|
|
|
May 15, 2024
Q1 2024
|
Steven Cohen
Point72 Asset Management, L.P. | Stamford, Ct
|
BUY
|
- |
600New |
N/A
|
600
$1.99K
|
|
|
May 15, 2024
Q1 2024
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
8New |
N/A
|
8
$26.5
|
|
|
May 10, 2024
Q1 2024
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
6+ 0.89% |
N/A
|
680
$2.25K
|
|
|
Apr 30, 2024
Q1 2024
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
N/A
|
0
$0
|
|
|
May 15, 2024
Q1 2024
|
Mariner, LLC
Overland Park, KS |
SELL
|
- |
-282- 2.69% |
N/A
|
10.2K
$33.8K
|
|
|
May 10, 2024
Q1 2024
|
Advisor Group Holdings, Inc.
Phoenix, AZ |
SELL
|
- |
-5.08K- 80.04% |
N/A
|
1.27K
$4.19K
|
|
|
May 09, 2024
Q1 2024
|
Rhumbline Advisers
Boston, MA |
SELL
|
- |
-5.4K- 74.45% |
N/A
|
1.85K
$6.13K
|
|
|
Nov 05, 2024
Q1 2024
|
Royal Bank Of Canada
Toronto, A6 |
SELL
|
- |
-5.87K- 78.75% |
N/A
|
1.59K
$5.25K
|
|
|
May 13, 2024
Q1 2024
|
Balyasny Asset Management LLC
Chicago, IL |
SELL
|
- |
-6.56K- 7.56% |
N/A
|
80.2K
$266K
|
|
|
May 15, 2024
Q1 2024
|
Rbf Capital, LLC
San Francisco, CA |
SELL
|
- |
-10K- 6.67% |
N/A
|
140K
$463K
|
|
|
May 13, 2024
Q1 2024
|
Ubs Group Ag
|
SELL
|
- |
-13.1K- 90.54% |
N/A
|
1.37K
$4.53K
|
|
|
May 10, 2024
Q1 2024
|
Black Rock Inc.
New York, NY |
SELL
|
- |
-23.4K- 2.6% |
N/A
|
877K
$2.9M
|
|
|
May 15, 2024
Q1 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-26.3K- 59.15% |
N/A
|
18.2K
$60.2K
|
|
|
May 06, 2024
Q1 2024
|
Marquette Asset Management, LLC
|
SELL
|
- |
-28.9K- 67.27% |
N/A
|
14.1K
$46.6K
|
|
|
May 13, 2024
Q1 2024
|
Jefferies Financial Group Inc.
New York, NY |
SELL
|
- |
-30.4K- 57.14% |
N/A
|
22.8K
$75.5K
|
|
|
May 10, 2024
Q1 2024
|
Citigroup Inc
|
SELL
|
- |
-68K- 25.21% |
N/A
|
202K
$668K
|
|
|
May 15, 2024
Q1 2024
|
683 Capital Management, LLC
New York, NY |
SELL
|
- |
-125K- 3.47% |
N/A
|
3.48M
$11.5M
|
|
|
May 10, 2024
Q1 2024
|
Acuitas Investments, LLC
|
SELL
|
- |
-131K- 63.0% |
N/A
|
77.2K
$256K
|
|
|
May 15, 2024
Q1 2024
|
Bain Capital Life Sciences Investors, LLC
Boston, MA |
SELL
|
- |
-138K- 7.1% |
N/A
|
1.8M
$5.96M
|
|
|
Oct 17, 2024
Q1 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-185K- 75.61% |
N/A
|
59.5K
$197K
|
|
|
May 15, 2024
Q1 2024
|
Bridgeway Capital Management, LLC
Houston, TX |
SELL
|
- |
-186K- 36.33% |
N/A
|
325K
$1.08M
|
|
|
May 02, 2024
Q1 2024
|
Alphabet Inc.
Mountain View, CA |
SELL
|
- |
-1.15M- 20.31% |
N/A
|
4.53M
$15M
|
|
|
May 15, 2024
Q1 2024
|
Orbimed Advisors LLC
San Diego, CA |
SELL
|
- |
-1.44M- 34.82% |
N/A
|
2.69M
$8.9M
|